Table 1.
Demographic and clinical data of all patients
| Variable | Normal group (n = 47) | CHB group (n = 51) | CHB + NAFLD group (n = 57) | P value |
| Age (yr) | 46.74 ± 6.97 | 36.76 ± 12.60 | 38.98 ± 13.55 | < 0.001 |
| Sex, n (%) | M: 29 (61.70) | M: 34 (66.67) | M: 42 (73.68) | 0.420 |
| F: 18 (38.30) | F: 17 (33.33) | F: 15 (26.32) | ||
| BMI (kg/m2) | 23.43 ± 2.59 | 22.84 ± 2.97 | 27.40 ± 3.24 | < 0.001 |
| TC (mmol/L) | 4.40 ± 1.22 | 4.39 ± 0.96 | 4.89 ± 0.84 | 0.023 |
| TG (mmol/L) | 0.98 ± 0.31 | 1.12 ± 0.38 | 1.84 ± 1.35 | < 0.001 |
| HDL (mmol/L) | 1.51 ± 1.22 | 1.50 ± 0.44 | 1.20 ± 0.28 | 0.142 |
| LDL (mmol/L) | 2.03 ± 0.85 | 2.22 ± 0.56 | 2.94 ± 1.02 | < 0.001 |
| FBG (mmol/L) | 3.39 ± 1.30 | 4.11 ± 0.63 | 5.71 ± 1.92 | < 0.001 |
| ALT (U/L) | 13. 72 ± 4.16 | 76.14 ± 53.70 | 68.51 ± 47.20 | < 0.001 |
| TBIL (μmol/L) | 2.25 ± 0.51 | 23.78 ± 21.44 | 5.80 ± 3.55 | < 0.001 |
| GGT (U/L) | 16.42 ± 7.31 | 94.33 ± 94.13 | 60.18 ± 36.81 | < 0.001 |
| ALP (U/L) | 16.08 ± 5.48 | 95.23 ± 40.35 | 101.16 ± 88.46 | < 0.001 |
CHB: Chronic hepatitis B; NAFLD: Nonalcoholic fatty liver disease; BMI: Body mass index; TC: Total cholesterol; TG: Triglyceride; HDL: High-density lipoprotein; LDL: Low-density lipoprotein; FBG: Fasting blood glucose; ALT: Alanine aminotransferase; TBIL: Total bilirubin; GGT: γ-glutamyltransferase; ALP: Alkaline phosphatase.